Abstract:Conjugation of folic acid (FA) onto the surface of nanocarriers for active targeting is the mainstream strategy to improve the targeting efficiency of delivery vehicles for enhanced anticancer drug delivery; however, this strategy suffers from the fast clearance of nanocarriers caused by an immunological response and the nonspecific cellular uptake of nanocarriers compromising therapeutic efficiency and causing serious side effects. To address this dilemma, a dual-functional sheddable monomethoxypolyethylene glycol (mPEG) stealth component for both protection of the FA targeting ligand and extracellular stabilization of the micelles was incorporated into the polymeric micelles to realize simultaneous tumor-triggered targeting and intracellular micelle destabilization for enhanced cellular uptake and drug release. Specifically, the mPEG stealth component containing a tumor acidic pH-cleavable hydrazone bond was linked to an FA-conjugated amphiphilic block-statistical copolymer, FA-poly(oligo(ethylene glycol)monomethyl ether methacrylate)-st-poly(2-hydroxyethyl methacrylate-g-lactide) (P(OEGMA300)-st-P(HEMA-g-LA))viahighly efficient click coupling. The deshielding of the mPEG stealth component at the weakly acidic pH of the tumor site can expose the FA targeting ligand that is shielded under physiological conditions for active targeting, and trigger the destabilization of the self-assembled micelles for accelerated drug release. Meanwhile, reducibly conjugating the FA targeting ligandviaa disulfide bond can further promote the targeting efficiency of the micelles by continuous folate receptor (FR)-mediated endocytosis. A panel of block-statistical copolymers with three different hydrophilic weight fractions was synthesized to investigate the structure-property relationship of this micelle construct. The optimized micelle formulation based on mPEG(FA)-P(OEGMA300)(4)-st-P(HEMA-g-LA)(4)is relatively stable at pH 7.4 with a hydrodynamic diameter (D-h) of 41 nm, and the intracellular simultaneous cleavage of the disulfide links and hydrazone bonds led to significantly promoted destabilization of the drug-loaded micelles for promoted drug release. Therefore, the adoption of a sheddable mPEG stealth component with dual functionalities for greater cellular uptake and faster drug release of micelles provides a powerful means of enhanced anticancer drug delivery.

Self-assembled micelles of a multi-functional amphiphilic fusion (MFAF) peptide for targeted cancer therapy

Folic Acid Grafted and Tertiary Amino Based Ph-Responsive Pentablock Polymeric Micelles for Targeting Anticancer Drug Delivery.

Polymer micelle with pH-triggered hydrophobic-hydrophilic transition and de-cross-linking process in the core and its application for targeted anticancer drug delivery.

Folate-conjugated pH-responsive nanocarrier designed for active tumor targeting and controlled release of doxorubicin

Multi-functional envelope-type nanoparticles assembled from amphiphilic peptidic prodrug with improved anti-tumor activity.

Doxorubicin-Loaded Micelles Based on Folic Acid Conjugated Ph-Dependent Thermo-Sensitive Copolymer: in Vitro and in Vivo Evaluation

Integrin-targeted pH-responsive micelles for enhanced efficiency of anticancer treatment in vitro and in vivo.

Stepwise-activable Multifunctional Peptide-Guided Prodrug Micelles for Cancerous Cells Intracellular Drug Release

Synthesis of polymeric micelles with dual-functional sheddable PEG stealth for enhanced tumor-targeted drug delivery

Design Of A Lysosome Targeting In Situ Self-Assembly Peptide And Its Antitumor Activity

Fabrication of a multifunctional nanomaterial from a mussel-derived peptide for multimodal synergistic cancer therapy

Anti-phagocytosis and tumor cell targeting micelles prepared from multifunctional cell membrane mimetic polymers

A Transformable Chimeric Peptide for Cell Encapsulation to Overcome Multidrug Resistance.

Combinatorial Targeting Polymeric Micelles for Anti-Tumor Drug Delivery.

Intracellular and extracellular enzymatic responsive micelle for intelligent therapy of cancer

Enzyme-Triggered Morphological Transition of Peptide Nanostructures for Tumor-Targeted Drug Delivery and Enhanced Cancer Therapy.

A Micelle Self-Assembled from Doxorubicin-Arabinoxylan Conjugates with Ph-Cleavable Bond for Synergistic Antitumor Therapy

pH responsive micelle self-assembled from a new amphiphilic peptide as anti-tumor drug carrier

Folate Ligand Orientation Optimized During Cell Membrane Mimetic Micelle Formation for Enhanced Tumor Cell Targeting

Ph-Responsive Polymeric Micelles Based on Poly(2-Ethyl-2-oxazoline)-poly(d,l-lactide) for Tumor-Targeting and Controlled Delivery of Doxorubicin and P-glycoprotein Inhibitor

Dimeric Drug Polymeric Micelles with Acid-Active Tumor Targeting and FRET-indicated Drug Release